Detalles de la búsqueda
1.
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial.
Lancet Oncol
; 15(3): 286-96, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24556040
2.
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial.
Lancet
; 372(9637): 449-56, 2008 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-18653228
3.
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer.
J Clin Oncol
; 36(1): 7-13, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29072975
4.
Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group.
J Clin Oncol
; 21(16): 3150-7, 2003 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12915606
5.
Skeletal complications in patients with bone metastases from renal cell carcinoma and therapeutic benefits of zoledronic acid.
Clin Cancer Res
; 10(18 Pt 2): 6397S-403S, 2004 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15448038
6.
Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial.
Cancer
; 100(12): 2613-21, 2004 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15197804
Resultados
1 -
6
de 6
1
Próxima >
>>